CytoReason vs Indica Labs
CytoReason vs Indica Labs, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Indica Labs on 53/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 53/100
- funding raised: $128M against $10.0M
Indica Labs
- agent readiness: 45/100 against 21/100
- domain rating: 51/100 against 40/100
At a glance
| Measure | CytoReason | Indica Labs |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Digital pathology software for AI-powered image analysis in research and clinical settings. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Digital Pathology, AI, Machine Learning, Image Analysis |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2011 |
| Headquarters | Tel Aviv, Israel | Albuquerque, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Indica Labs |
|---|---|---|
| Employees | 116 | 118 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | $10.0M |
| Latest round | Series B | Series A |
| LinkedIn followers | 12,830 | 11,687 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Indica Labs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 53/100 |
| Traction | 60/100 | 55/100 |
| Team | 70/100 | Not published |
| Search visibility | 30/100 | 34/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 51/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Indica Labs |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Segment | Not detected |
CytoReason vs Indica Labs: common questions
Which is better, CytoReason or Indica Labs?
On our 0-100 score CytoReason rates higher (68/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CytoReason and Indica Labs compare on the numbers?
CytoReason leads on our overall score (68/100 against 53/100), funding raised ($128M against $10.0M). Indica Labs leads on agent readiness (45/100 against 21/100), domain rating (51/100 against 40/100).
Read the full CytoReason review and pricing or the Indica Labs review and pricing. You can also browse other CytoReason alternatives we track.